<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="letter" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Euro Surveill</journal-id><journal-id journal-id-type="iso-abbrev">Euro Surveill</journal-id><journal-id journal-id-type="pmc-domain-id">3033</journal-id><journal-id journal-id-type="pmc-domain">eurosurv</journal-id><journal-id journal-id-type="publisher-id">eurosurveillance</journal-id><journal-title-group><journal-title>Eurosurveillance</journal-title></journal-title-group><issn pub-type="ppub">1025-496X</issn><issn pub-type="epub">1560-7917</issn><publisher><publisher-name>European Centre for Disease Prevention and Control</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC12475891</article-id><article-id pub-id-type="pmcid-ver">PMC12475891.1</article-id><article-id pub-id-type="pmcaid">12475891</article-id><article-id pub-id-type="pmcaiid">12475891</article-id><article-id pub-id-type="pmid">41000026</article-id><article-id pub-id-type="doi">10.2807/1560-7917.ES.2025.30.38.2500659</article-id><article-id pub-id-type="publisher-id">2500659</article-id><article-id pub-id-type="publisher-id">2500659</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Letter</subject></subj-group></article-categories><title-group><article-title>Letter to the editor: Towards effective implementation of hospital-onset bacteraemia and fungaemia as a quality metric</article-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-4665-8284</contrib-id><name name-style="western"><surname>Forni</surname><given-names initials="S">Silvia</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-1258-1650</contrib-id><name name-style="western"><surname>Arzilli</surname><given-names initials="G">Guglielmo</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><xref rid="aff2" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-1266-8433</contrib-id><name name-style="western"><surname>Gemmi</surname><given-names initials="F">Fabrizio</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-4817-8337</contrib-id><name name-style="western"><surname>Comelli</surname><given-names initials="A">Agnese</given-names></name><xref rid="aff3" ref-type="aff">
<sup>3</sup>
</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-3331-2815</contrib-id><name name-style="western"><surname>Del Castillo</surname><given-names initials="G">Gabriele</given-names></name><xref rid="aff3" ref-type="aff">
<sup>3</sup>
</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-0753-8853</contrib-id><name name-style="western"><surname>Villa</surname><given-names initials="S">Simone</given-names></name><xref rid="aff3" ref-type="aff">
<sup>3</sup>
</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-0499-2505</contrib-id><name name-style="western"><surname>Banchelli</surname><given-names initials="F">Federico</given-names></name><xref rid="aff4" ref-type="aff">
<sup>4</sup>
</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-9976-9359</contrib-id><name name-style="western"><surname>Ricchizzi</surname><given-names initials="E">Enrico</given-names></name><xref rid="aff4" ref-type="aff">
<sup>4</sup>
</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-9855-2924</contrib-id><name name-style="western"><surname>D&#8217;Ancona</surname><given-names initials="F">Fortunato</given-names></name><xref rid="aff5" ref-type="aff">
<sup>5</sup>
</xref></contrib><aff id="aff1">
<label>1</label>Regional Health Agency of Tuscany, Florence, Italy</aff><aff id="aff2">
<label>2</label>Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy</aff><aff id="aff3">
<label>3</label>Directorate General for Health, Lombardy Region, Milan, Italy</aff><aff id="aff4">
<label>4</label>Directorate General for Personal Care, Health and Welfare, Bologna, Italy</aff><aff id="aff5">
<label>5</label>Department of Infectious Diseases, Istituto Superiore Di Sanit&#224;, Rome, Italy</aff></contrib-group><author-notes><fn id="afn1"><p>
<bold>Correspondence</bold>: Guglielmo Arzilli (<email xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="guglielmo.arzilli@phd.unipi.it">guglielmo.arzilli@phd.unipi.it</email>)</p></fn></author-notes><pub-date pub-type="ppub"><day>25</day><month>9</month><year>2025</year></pub-date><volume>30</volume><issue seq="4">38</issue><issue-id pub-id-type="pmc-issue-id">497703</issue-id><elocation-id>2500659</elocation-id><history><date date-type="received"><day>27</day><month>8</month><year>2025</year></date><date date-type="accepted"><day>03</day><month>9</month><year>2025</year></date></history><pub-history><event event-type="pmc-release"><date><day>25</day><month>09</month><year>2025</year></date></event><event event-type="pmc-live"><date><day>28</day><month>09</month><year>2025</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2025-09-28 18:25:14.327"><day>28</day><month>09</month><year>2025</year></date></event></pub-history><permissions><copyright-statement>This article is copyright of the authors or their affiliated institutions, 2025.</copyright-statement><copyright-year>2025</copyright-year><copyright-holder>The authors or their affiliated institutions</copyright-holder><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution (CC BY 4.0) Licence. You may share and adapt the material, but must give appropriate credit to the source, provide a link to the licence, and indicate if changes were made.</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="eurosurv-30-38-4.pdf"/><related-article xmlns:xlink="http://www.w3.org/1999/xlink" related-article-type="letter" xml:lang="en" xlink:title="research-article" vol="30" journal-id="Euro Surveill" journal-id-type="nlm-ta" ext-link-type="pmc" xlink:href="PMC12180293"><article-title>Hospital-onset bacteraemia and fungaemia as a novel automated surveillance indicator: results from four European university hospitals, 2018 to 2022</article-title><volume>30</volume><issue seq="1">24</issue><date><day>19</day><month>6</month><year>2025</year></date><elocation-id>2400613</elocation-id><source>Eurosurveillance</source><pub-id pub-id-type="doi">10.2807/1560-7917.ES.2025.30.24.2400613</pub-id><pub-id pub-id-type="pmcid">PMC12180293</pub-id><pub-id pub-id-type="pmid">40539312</pub-id></related-article><kwd-group><title>Keywords: </title><kwd>hospital-onset bacteraemia and fungaemia</kwd><kwd>HOB</kwd><kwd>automated surveillance</kwd><kwd>electronic health records</kwd><kwd>bloodstream infection</kwd><kwd>indicator</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>sequence</meta-name><meta-value>4</meta-value></custom-meta></custom-meta-group></article-meta></front><body><p>
<bold>To the editor: </bold>We read with great interest the article by Aghdassi et al. [<xref rid="r1" ref-type="bibr">1</xref>], which represents a notable step forward in the development of automated surveillance for hospital-onset bacteraemia and fungaemia (HOB). While recognising its value for surveillance, we would like to suggest how to improve the use of the HOB rate as a key performance indicator for measuring quality of care. </p><p>Firstly, misclassification in HOB estimates could arise from different data collection protocols and diagnostic stewardship. As noted by Aghdassi et al. [<xref rid="r1" ref-type="bibr">1</xref>], adopting data structures that support interoperability across institutions is essential for automated surveillance. This requires large-scale standardised protocols for real-time microbiological data collection, based on common definitions and aligned with international standards, which can be integrated with other electronic health records (EHRs). In addition, a combined monitoring approach, incorporating the incidence of HOB, the number of blood cultures performed and the number of bloodstream infections sustained by common commensals, offers a more robust framework for developing and implementing strategies to reduce HOB. Moreover, HOB incidence is closely linked to the characteristics and organisation of the hospitals [<xref rid="r2" ref-type="bibr">2</xref>]. Aghdassi et al. showed that, within a hospital network, patient movements were classified as transfers rather than repeated admissions, considering the time spent at each facility and allowing for longer patient monitoring to better assess the overall HOB incidence across the network [<xref rid="r1" ref-type="bibr">1</xref>]. Drawing on this observation, incorporating information on inter-hospital transfers or readmissions would help mitigate the risk of misclassification in the estimation of HOBs [<xref rid="r3" ref-type="bibr">3</xref>].</p><p>Secondly, the usefulness of the HOB indicator is closely linked to preventability of HOBs. In the Discussion section, the authors highlight the need for future research aimed at characterising &#8216;<italic toggle="yes">the conditions underlying HOB episodes, assess preventability and effective interventions</italic>&#8217; [<xref rid="r1" ref-type="bibr">1</xref>]. Leekha et al. estimate that 36% of non-commensal HOBs are preventable [<xref rid="r4" ref-type="bibr">4</xref>], effectively opening opportunities for improvement in prevention, in line with what has been observed for widely used quality and safety indicators, such as in-hospital mortality or readmissions [<xref rid="r5" ref-type="bibr">5</xref>]. However, this aspect raises a new issue related to the extent of human and financial resources needed to analyse cases and develop an improvement plan. Since the proportion of preventable cases may be low, especially in high-risk patients, a substantial number of cases should be reviewed to identify potentially preventable infections. This challenge is particularly relevant when compared with the central line&#8211;associated bloodstream infections (CLABSI) indicator, where the proportion of preventable infections is higher and the workload for infection prevention staff to analyse cases and develop an improvement plan is lower than for HOBs. One strategy to address this problem is to exclude from the indicator patients with high-risk conditions, e.g. neutropenia, immunosuppression [<xref rid="r6" ref-type="bibr">6</xref>].</p><p>Finally, specific attention should be paid to the intended purpose of using this indicator. Aghdassi et al. emphasise that this indicator can detect temporary increases in the same hospital such as those observed during the COVID-19 pandemic between 2020 and 2021 [<xref rid="r1" ref-type="bibr">1</xref>], highlighting potential vulnerabilities in the quality of care and patient safety [<xref rid="r3" ref-type="bibr">3</xref>]. However, in different contexts, such as value-based programs or for benchmarking, risk adjustment methods must be used to assess differences in the patients&#8217; case mix across hospitals [<xref rid="r6" ref-type="bibr">6</xref>].</p><p>In relation to the above aspects, three Italian regions (Tuscany, Emilia-Romagna and Lombardy) are participating in a project coordinated by the National Institute of Health (ISS), within the European initiative &#8216;Surveillance from Electronic Health Data&#8217; (SUREHD) funded by the European Centre for Disease Prevention and Control (ECDC) [<xref rid="r7" ref-type="bibr">7</xref>], which aims to define and test a shared protocol for the surveillance of bloodstream infections based on EHRs in European Union/European Economic Area (EU/EEA) countries.</p><p>In response to some of the points raised, the Italian SUREHD project plans to: (i) develop a hospital-level algorithm to estimate HOB incidence, define priorities, and track progress, without inter-hospital benchmarking; (ii) monitor blood culture rates and possibly restrict surveillance to pathogens with reliable data and established diagnostics; (iii) include most regional public hospitals, accounting for transfers and readmissions to reduce bias in defining HOB.</p><p>In conclusion, we agree with Aghdassi et al. that the introduction of automated HOB surveillance could represent a remarkable advancement in infection prevention and control. To maximise its effectiveness as a quality and safety indicator, it is essential to address additional challenges related to the accurate identification of bloodstream infections, evaluate their preventability and potential intervention strategies and clearly define its intended purpose, i.e. benchmarking, quality improvement or research.</p></body><back><ack><title>Use of artificial intelligence</title><p>AI was used to improve the English text and for proofreading. No content was generated by AI or left unreviewed.</p></ack><notes><fn-group><fn fn-type="con"><p><bold>Authors&#8217; contributions:</bold> Silvia Forni and Guglielmo Arzilli conceived the idea of the letter and drafted the original version, with methodological input from Fortunato D&#8217;Ancona. Fabrizio Gemmi, Agnese Comelli, Gabriele Del Castillo, Simone Villa, Federico Banchelli, and Enrico Ricchizzi critically reviewed the content and provided important intellectual input. All authors revised the manuscript and approved the final version. </p></fn><fn fn-type="COI-statement"><p><bold>Conflict of interest:</bold> None declared.</p></fn></fn-group></notes><ref-list><title>References</title><ref id="r1"><label>1</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Aghdassi</surname><given-names>SJ</given-names></name><name name-style="western"><surname>van der Werff</surname><given-names>SD</given-names></name><name name-style="western"><surname>Catho</surname><given-names>G</given-names></name><name name-style="western"><surname>Brekelmans</surname><given-names>M</given-names></name><name name-style="western"><surname>Pe&#241;a Diaz</surname><given-names>LA</given-names></name><name name-style="western"><surname>Buetti</surname><given-names>N</given-names></name><etal/></person-group><article-title>Hospital-onset bacteraemia and fungaemia as a novel automated surveillance indicator: results from four European university hospitals, 2018 to 2022.</article-title><source>Euro Surveill</source>. <year>2025</year>;<volume>30</volume>(<issue>24</issue>):<elocation-id>2400613</elocation-id>. <pub-id pub-id-type="doi">10.2807/1560-7917.ES.2025.30.24.2400613</pub-id><pub-id pub-id-type="pmid">40539312</pub-id><pub-id pub-id-type="pmcid">PMC12180293</pub-id></mixed-citation></ref><ref id="r2"><label>2</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yu</surname><given-names>KC</given-names></name><name name-style="western"><surname>Ye</surname><given-names>G</given-names></name><name name-style="western"><surname>Edwards</surname><given-names>JR</given-names></name><name name-style="western"><surname>Gupta</surname><given-names>V</given-names></name><name name-style="western"><surname>Benin</surname><given-names>AL</given-names></name><name name-style="western"><surname>Ai</surname><given-names>C</given-names></name><etal/></person-group><article-title>Hospital-onset bacteremia and fungemia: An evaluation of predictors and feasibility of benchmarking comparing two risk-adjusted models among 267 hospitals.</article-title><source>Infect Control Hosp Epidemiol</source>. <year>2022</year>;<volume>43</volume>(<issue>10</issue>):<fpage>1317</fpage>-<lpage>25</lpage>. <pub-id pub-id-type="doi">10.1017/ice.2022.211</pub-id><pub-id pub-id-type="pmid">36082774</pub-id><pub-id pub-id-type="pmcid">PMC9588439</pub-id></mixed-citation></ref><ref id="r3"><label>3</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Brekelmans</surname><given-names>MACM</given-names></name><name name-style="western"><surname>Vlek</surname><given-names>ALM</given-names></name><name name-style="western"><surname>van Dijk</surname><given-names>Y</given-names></name><name name-style="western"><surname>Smilde</surname><given-names>AE</given-names></name><name name-style="western"><surname>Weersink</surname><given-names>AJL</given-names></name><name name-style="western"><surname>Wunderink</surname><given-names>HF</given-names></name><etal/></person-group><article-title>Automated surveillance of hospital-onset bacteremia and fungemia: feasibility and epidemiological results from a Dutch multicenter study.</article-title><source>Infect Control Hosp Epidemiol</source>. <year>2025</year>;<volume>46</volume>(<issue>5</issue>):<fpage>1</fpage>-<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1017/ice.2025.29</pub-id><pub-id pub-id-type="pmid">40007429</pub-id><pub-id pub-id-type="pmcid">PMC12034453</pub-id></mixed-citation></ref><ref id="r4"><label>4</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Leekha</surname><given-names>S</given-names></name><name name-style="western"><surname>Robinson</surname><given-names>GL</given-names></name><name name-style="western"><surname>Jacob</surname><given-names>JT</given-names></name><name name-style="western"><surname>Fridkin</surname><given-names>S</given-names></name><name name-style="western"><surname>Shane</surname><given-names>A</given-names></name><name name-style="western"><surname>Sick-Samuels</surname><given-names>A</given-names></name><etal/></person-group><article-title>Evaluation of hospital-onset bacteraemia and fungaemia in the USA as a potential healthcare quality measure: a cross-sectional study.</article-title><source>BMJ Qual Saf</source>. <year>2024</year>;<volume>33</volume>(<issue>8</issue>):<fpage>487</fpage>-<lpage>98</lpage>. <pub-id pub-id-type="doi">10.1136/bmjqs-2023-016831</pub-id><pub-id pub-id-type="pmid">38782579</pub-id><pub-id pub-id-type="pmcid">PMC11287649</pub-id></mixed-citation></ref><ref id="r5"><label>5</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rhee</surname><given-names>C</given-names></name><name name-style="western"><surname>Patel</surname><given-names>P</given-names></name><name name-style="western"><surname>Szymczak</surname><given-names>J</given-names></name></person-group>. <article-title>Is hospital-onset bacteraemia and fungaemia an actionable quality measure?</article-title><source>BMJ Qual Saf</source>. <year>2024</year>;<volume>33</volume>(<issue>8</issue>):<fpage>479</fpage>-<lpage>82</lpage>. <pub-id pub-id-type="doi">10.1136/bmjqs-2024-017292</pub-id><pub-id pub-id-type="pmid">38802245</pub-id></mixed-citation></ref><ref id="r6"><label>6</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schrank</surname><given-names>GM</given-names></name><name name-style="western"><surname>Madaline</surname><given-names>T</given-names></name></person-group>. <article-title>Hospital onset bacteremia and fungemia should be a pay-for performance measure: a pro/con debate.</article-title><source>Infect Control Hosp Epidemiol</source>. <year>2025</year>;<fpage>1</fpage>-<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1017/ice.2025.10216</pub-id><pub-id pub-id-type="pmid">40671597</pub-id></mixed-citation></ref><ref id="r7"><label>7</label><mixed-citation publication-type="webpage">European Commission (EC). EU Funding &amp; Tenders Portal. Design and Implementation of Multinational Surveillance Systems Using Routinely Collected Electronic Health Records in EU/EEA. Brussels: EC; 2022. Available from: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/opportunities/tender-details/9819" ext-link-type="uri">https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/opportunities/tender-details/9819</ext-link></mixed-citation></ref></ref-list></back></article></pmc-articleset>